Legault Pierre
Insider CIK 1391045 · RGDO Director · NRX Chief Executive Officer, Director · SNDX Director · ARMO Director · UROV Director · BCYC Director · FRX Director · NPSP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals Inc | A Award | 2026-02-04 | 2026-02-06 | 24,000 | — | $0 | 114,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 90,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS PLC | A Award deriv | 2025-01-02 | 2025-01-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS PLC | A Award | 2025-01-02 | 2025-01-06 | 12,500 | — | $0 | 46,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 65,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2024-01-02 | 2024-01-04 | 24,000 | — | $0 | 24,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award | 2024-01-02 | 2024-01-04 | 12,000 | — | $0 | 33,500 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2023-02-02 | 2023-02-03 | 16,000 | — | $0 | 48,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2023-01-13 | 2023-01-13 | 5,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2023-01-13 | 2023-01-13 | 10,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2023-01-13 | 2023-01-13 | 5,000 | $13.58 | $67.9K | 37,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2023-01-13 | 2023-01-13 | 10,000 | $27.00 | $270.0K | 32,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2023-01-13 | 2023-01-13 | 10,000 | $13.58 | $135.8K | 42,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2023-01-13 | 2023-01-13 | 5,000 | $27.00 | $135.0K | 32,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2023-01-12 | 2023-01-13 | 24,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2023-01-12 | 2023-01-13 | 24,000 | $9.47 | $227.3K | 56,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2023-01-12 | 2023-01-13 | 24,000 | $26.74 | $641.8K | 32,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2023-01-03 | 2023-01-05 | 23,000 | — | $0 | 23,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award | 2023-01-03 | 2023-01-05 | 11,500 | — | $0 | 21,500 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2022-08-05 | 2022-08-09 | 14,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2022-08-05 | 2022-08-09 | 10,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2022-08-05 | 2022-08-09 | 14,000 | $23.02 | $322.3K | 32,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2022-08-05 | 2022-08-09 | 14,000 | $8.93 | $125.0K | 46,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2022-08-05 | 2022-08-09 | 10,000 | $23.02 | $230.2K | 32,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2022-08-05 | 2022-08-09 | 10,000 | $9.63 | $96.3K | 42,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2022-01-03 | 2022-01-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2021-12-22 | 2021-12-22 | 24,000 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-12-22 | 2021-12-22 | 97,860 | — | $0 | 23,312 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2021-12-22 | 2021-12-22 | 24,000 | $7.88 | $189.1K | 40,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2021-12-22 | 2021-12-22 | 24,000 | $22.01 | $528.2K | 16,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-12-22 | 2021-12-22 | 97,860 | $8.48 | $829.9K | 97,860 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-12-22 | 2021-12-22 | 97,860 | $58.01 | $5.68M | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-12-21 | 2021-12-22 | 44,537 | — | $0 | 121,172 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-12-21 | 2021-12-22 | 44,537 | $57.11 | $2.54M | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-12-21 | 2021-12-22 | 44,537 | $8.44 | $375.9K | 44,537 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2021-12-20 | 2021-12-22 | 20,000 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-12-20 | 2021-12-22 | 7,603 | — | $0 | 165,709 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2021-12-20 | 2021-12-22 | 20,000 | $7.08 | $141.6K | 36,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2021-12-20 | 2021-12-22 | 20,000 | $21.01 | $420.2K | 16,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-12-20 | 2021-12-22 | 7,603 | $8.41 | $63.9K | 7,603 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-12-20 | 2021-12-22 | 7,603 | $57.02 | $433.5K | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-04-08 | 2021-04-09 | 24,838 | — | $0 | 173,312 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-04-08 | 2021-04-09 | 239 | $32.13 | $7.7K | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-04-08 | 2021-04-09 | 12,099 | $31.40 | $379.9K | 239 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-04-08 | 2021-04-09 | 12,500 | $32.00 | $400.0K | 12,338 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-04-08 | 2021-04-09 | 24,838 | $8.74 | $217.1K | 24,838 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-04-05 | 2021-04-07 | 162 | — | $0 | 198,150 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-04-05 | 2021-04-07 | 162 | $31.07 | $5.0K | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-04-05 | 2021-04-07 | 162 | $8.83 | $1.4K | 162 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-03-31 | 2021-04-02 | 10,000 | — | $0 | 198,312 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-03-31 | 2021-04-02 | 10,000 | $30.00 | $300.0K | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-03-31 | 2021-04-02 | 10,000 | $8.78 | $87.8K | 10,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 25,000 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 15,000 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 36,650 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 13,350 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer | 2021-03-29 | 2021-03-31 | 9,000 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer | 2021-03-29 | 2021-03-31 | 12,480 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-03-17 | 2021-03-19 | 7,784 | — | $0 | 208,312 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-03-17 | 2021-03-19 | 7,784 | $8.85 | $68.9K | 7,784 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-03-17 | 2021-03-19 | 7,784 | $29.00 | $225.7K | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise deriv | 2021-03-12 | 2021-03-16 | 2,216 | — | $0 | 216,096 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | S Sale | 2021-03-12 | 2021-03-16 | 2,216 | $29.00 | $64.3K | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | M Exercise | 2021-03-12 | 2021-03-16 | 2,216 | $8.86 | $19.6K | 2,216 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2021-02-03 | 2021-02-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2021-01-04 | 2021-01-05 | 38,000 | — | $0 | 38,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2020-07-21 | 2020-07-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award | 2020-07-21 | 2020-07-23 | 9,000 | — | $0 | 21,480 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2020-02-12 | 2020-02-14 | 24,000 | — | $0 | 24,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award | 2020-01-10 | 2020-01-14 | 12,480 | — | $0 | 12,480 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2020-01-02 | 2020-01-06 | 32,000 | — | $0 | 32,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2019-06-28 | 2020-04-27 | 116,827 | — | $0 | 116,827 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2019-06-10 | 2019-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2019-05-28 | 2019-05-30 | 116,827 | — | $0 | 116,827 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2018-11-21 | 2018-11-26 | 36,650 | — | $0 | 36,650 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | D To issuer deriv | 2018-06-22 | 2018-06-22 | 55,765 | $43.27 | $2.41M | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2018-05-23 | 2018-05-25 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2018-02-08 | 2018-02-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2017-05-17 | 2017-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2017-05-17 | 2017-05-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2017-01-04 | 2017-01-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 15,500 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 6,111 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 17,695 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 17,778 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 535 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 17,778 | — | $0 | 17,778 | SEC↗ |
| NRX NephroGenex, Inc. | A Award | 2015-11-10 | 2015-11-12 | 646,930 | — | $0 | 659,430 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-07-09 | 2015-07-13 | 15,500 | — | $0 | 15,500 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2015-04-30 | 2015-05-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 20,257 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 3,816 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 3,816 | — | $0 | 3,816 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2015-01-01 | 2015-01-05 | 159,261 | — | $0 | 159,261 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-12-12 | 2014-12-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-11-03 | 2014-11-05 | 20,257 | — | $0 | 20,257 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 20,000 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 5,909 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 1,320 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 441 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-05-15 | 2014-05-16 | 24,686 | — | $0 | 24,686 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-05-15 | 2014-05-16 | 76,156 | — | $0 | 76,156 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-05-15 | 2014-05-16 | 38,078 | — | $0 | 38,078 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-05-15 | 2014-05-16 | 12,343 | — | $0 | 12,343 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2014-01-01 | 2014-01-03 | 4,820 | — | $0 | 4,820 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2013-08-15 | 2013-08-16 | 5,909 | — | $0 | 5,909 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2013-08-15 | 2013-08-16 | 1,761 | — | $0 | 1,761 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2012-08-23 | 2012-08-27 | 20,000 | — | $0 | 20,000 | SEC↗ |